Concepedia

Barbara M. Bryant

BM

26

Publications

5.5K

Citations

22

H-Index

1996

Active since

Affiliations

Constellation Pharmaceuticals (United States)(Current)

Millennium Engineering and Integration (United States)

Mayo Clinic in Arizona

University of Pennsylvania

Harvard University

Barbara M. Bryant is an author at Constellation Pharmaceuticals (United States) specializing in medicine, cell biology, and cancer research.

ORCID

Top concepts

Publications per year

1996–2019

26

Publications

26

Targeting MYC dependence in cancer by inhibiting BET bromodomains

Jennifer A. Mertz, Andrew R. Conery, Barbara M. Bryant et al. · Proceedings of the National Academy of Sciences · 2011 · 1.1K citations · Full text

, , +15

Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma

Jonathan J. Keats, Rafaël Fonseca, Marta Chesi et al. · Cancer Cell · 2007 · 980 citations · Full text

, , +7

Characterizing gene sets with FuncAssociate

Gabriel F. Berriz, Oliver D. King, Barbara M. Bryant et al. · Bioinformatics · 2003 · 467 citations · Full text

Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib

George Mulligan, Constantine S. Mitsiades, Barbara M. Bryant et al. · Blood · 2006 · 409 citations · Full text

Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen

Michael P. Menden, Dennis Wang, Mike J. Mason et al. · Nature Communications · 2019 · 350 citations · Full text

Rows per page

1–5 of 26